We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
13501
PUT
Lyell Immunopharma
LYEL
$343M
-610
Closed -$62K
MAIN icon
13502
Main Street Capital
MAIN
$5.5B
-118,737
Closed -$4.64M
MAMB
13503
Monarch Ambassador Income Index ETF
MAMB
$195M
-18,657
Closed -$448K
MAS icon
13504
Masco
MAS
$14.6B
-356,086
Closed -$18.8M
MATV icon
13505
PUT
Mativ Holdings
MATV
$662M
-11,000
Closed -$303K
MATH icon
13506
Metalpha Technology Holding
MATH
$37.5M
-16,181
Closed -$17K
MAV
13507
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
-11,876
Closed -$117K
MBB icon
13508
iShares MBS ETF
MBB
$39.1B
-19,653
Closed -$1.93M
MBIO icon
13509
PUT
Mustang Bio
MBIO
$4.5M
-14
Closed -$10K
MBOT icon
13510
Microbot Medical
MBOT
$109M
-14,847
Closed -$93K
MBSD icon
13511
FlexShares Disciplined Duration MBS Index Fund
MBSD
$89M
-167,895
Closed -$3.7M
MCB icon
13512
CALL
Metropolitan Bank Holding Corp
MCB
$1.16B
-7,400
Closed -$753K
MCFT icon
13513
CALL
MasterCraft Boat Holdings
MCFT
$590M
-10,800
Closed -$266K
MCRI icon
13514
Monarch Casino & Resort
MCRI
$2.23B
-3,512
Closed -$246K
MCY icon
13515
PUT
Mercury Insurance
MCY
$5.84B
-8,100
Closed -$446K
MDIV icon
13516
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$432M
-12,473
Closed -$210K
MDU icon
13517
PUT
MDU Resources
MDU
$4.35B
-49,442
Closed -$501K
MDWD icon
13518
PUT
MediWound
MDWD
$174M
-1,786
Closed -$25K
ONT
13519
PUT
Onterris Inc
ONT
$629M
-5,100
Closed -$270K
MEGI
13520
MainStay CBRE Global Infrastructure Megatrends Term Fund
MEGI
$792M
-10,964
Closed -$208K
MERC icon
13521
CALL
Mercer International
MERC
$32.2M
-11,900
Closed -$166K
RJET
13522
PUT
Republic Airways Holdings
RJET
$956M
-1,533
Closed -$101K
MFIN icon
13523
CALL
Medallion Financial
MFIN
$263M
-12,200
Closed -$104K
MG icon
13524
PUT
Mistras Group
MG
$578M
-24,700
Closed -$163K
MGC icon
13525
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
-1,606
Closed -$255K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.